ExtraLife

ExtraLife is an active health-focused company and platform operating at the intersection of decentralized science, consumer health optimization, and regenerative medicine education. The company presents itself as an AI-enabled, biomarker-driven platform that offers research content, custom protocols, and community-oriented funding initiatives for frontier health areas. Its most visible disease-focused initiative is in tinnitus and hearing research, where it promotes an investigational framework combining peptide therapy, stem cell treatment, molecular hydrogen inhalation, neural plasticity techniques, and AI-powered biomarker tracking. ExtraLife also publishes content around cognitive optimization, regenerative medicine, and functional health protocols. Based on publicly available information, it appears to be an early-stage private company/platform rather than a traditional clinical-stage biotech developer with a disclosed therapeutic pipeline.